CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.60−0.01 (-1.15%)
Close on Nov 18, 2026Market cap $16.09MP/E –Yield –
CVRx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
CVRx's revenue for the twelve months ending Jun 30, 2026 was $61.19M, up 12.0% year over year. For fiscal 2025 it was $56.65M, up 10.4% from the year before. The highest annual figure on record is $56.65M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.65M | +10.4% |
| FY2024 | Dec 31, 2024 | $51.29M | +30.5% |
| FY2023 | Dec 31, 2023 | $39.30M | +74.9% |
| FY2022 | Dec 31, 2022 | $22.47M | +72.4% |
| FY2021 | Dec 31, 2021 | $13.04M | +115.4% |
| FY2020 | Dec 31, 2020 | $6.05M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.71M | +15.6% |
| Q1 FY2026 | Mar 31, 2026 | $14.77M | +19.6% |
| Q4 FY2025 | Dec 31, 2025 | $16.02M | +4.4% |
| Q3 FY2025 | Sep 30, 2025 | $14.69M | +9.8% |
| Q2 FY2025 | Jun 30, 2025 | $13.59M | +15.1% |
| Q1 FY2025 | Mar 31, 2025 | $12.35M | +14.7% |
| Q4 FY2024 | Dec 31, 2024 | $15.34M | +35.7% |
| Q3 FY2024 | Sep 30, 2024 | $13.37M | +27.2% |
| Q2 FY2024 | Jun 30, 2024 | $11.81M | +24.3% |
| Q1 FY2024 | Mar 31, 2024 | $10.77M | +35.0% |
| Q4 FY2023 | Dec 31, 2023 | $11.31M | +57.5% |
| Q3 FY2023 | Sep 30, 2023 | $10.51M | +69.9% |
| Q2 FY2023 | Jun 30, 2023 | $9.50M | +88.8% |
| Q1 FY2023 | Mar 31, 2023 | $7.98M | +95.8% |
| Q4 FY2022 | Dec 31, 2022 | $7.18M | +96.2% |
| Q3 FY2022 | Sep 30, 2022 | $6.19M | +82.2% |
| Q2 FY2022 | Jun 30, 2022 | $5.03M | +61.1% |
| Q1 FY2022 | Mar 31, 2022 | $4.08M | +42.5% |
| Q4 FY2021 | Dec 31, 2021 | $3.66M | +75.2% |
| Q3 FY2021 | Sep 30, 2021 | $3.40M | +240.5% |
| Q2 FY2021 | Jun 30, 2021 | $3.12M | +149.8% |
| Q1 FY2021 | Mar 31, 2021 | $2.86M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.09M | – |
| Q3 FY2020 | Sep 30, 2020 | $997.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $1.25M | – |
See a number that looks wrong?